Neonatal Aicardi–Goutières syndrome presenting with macrophage activation syndrome-like hyperinflammation and severe congenital glaucoma: a case report

This publication has 25 references indexed in Scilit:

• Efficacy of JAK1/2 inhibitors in AGS genes-related interferonopathies: A multicenter retrospective observational study with treated vs untreated comparison
  Molecular Genetics and Metabolism, 2026
• Chronic interferon-alpha overexpression induces white matter damage and neurovascular abnormalities in a mouse model of Aicardi-Goutières syndrome
  Experimental Neurology, 2025
• JAK inhibition in the type I interferonopathies
  Journal of Allergy and Clinical Immunology, 2021
• Ruxolitinib in Aicardi-Goutières syndrome
  Metabolic Brain Disease, 2021
• Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients
  Pediatric Neurology, 2018
• Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi–Goutières Syndrome and Beyond
  Neuropediatrics, 2016
• Aicardi–Goutières syndrome and the type I interferonopathies
  Nature Reviews Immunology, 2015
• Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1
  American Journal of Medical Genetics Part A, 2015
• Regulation of type I interferon responses
  Nature Reviews Immunology, 2013
• Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
  The Lancet Neurology, 2013